Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glycoprotein Ib-IX-V.

R K Andrews1, E E Gardiner, Y Shen

  • 1Vascular Biology Laboratory, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic. 3168, Australia. rob.andrews@med.monash.edu.au

The International Journal of Biochemistry & Cell Biology
|May 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.

Journal of thrombosis and haemostasis : JTH·2018
Same author

An exit strategy for new platelets.

Blood·2018
Same author

Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment.

Journal of thrombosis and haemostasis : JTH·2017
Same author

The influence of platelet membranes on tumour cell behaviour.

Cancer metastasis reviews·2017
Same author

Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.

Platelets·2016
Same journal

Corrigendum to "Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels" [Int. J. Biochem. Cell Biol. 42 (2010) 1840-1846].

The international journal of biochemistry & cell biology·2026
Same journal

Whole-brain spatial metabolomics reveals metabolic gradient shifts in a murine glioma model following boron neutron capture therapy (130 characters).

The international journal of biochemistry & cell biology·2026
Same journal

LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions.

The international journal of biochemistry & cell biology·2026
Same journal

Chloroquine modulates the redox-sensitive signalling via inhibiting the AMPK-ULK1 under LPS induced state in murine splenic macrophages.

The international journal of biochemistry & cell biology·2026
Same journal

The vicious cycle of hyperglycemia and oxidative stress: Novel mechanistic insights into a pathogenic alliance.

The international journal of biochemistry & cell biology·2026
Same journal

Fibroblast growth factors (FGF) in the pathogenesis and treatment of inflammatory bowel diseases (IBD): An overview.

The international journal of biochemistry & cell biology·2026
See all related articles

Glycoprotein Ib-IX-V is a key platelet receptor initiating clot formation under high shear stress. This receptor also plays a role in inflammation by interacting with neutrophils and activated platelets.

Area of Science:

  • Hematology
  • Molecular Biology
  • Immunology

Background:

  • Platelet adhesion receptors are crucial for hemostasis and thrombosis.
  • Glycoprotein (GP) Ib-IX-V is a significant receptor involved in platelet function.
  • Its role extends beyond simple adhesion to complex vascular interactions.

Purpose of the Study:

  • To elucidate the multifaceted roles of the Glycoprotein Ib-IX-V receptor.
  • To highlight its involvement in both thrombosis and inflammation.
  • To underscore its potential as a therapeutic target.

Main Methods:

  • Review of existing literature on Glycoprotein Ib-IX-V.
  • Analysis of receptor-ligand interactions.
  • Examination of its role in high-shear stress conditions.

Related Experiment Videos

Main Results:

  • Glycoprotein Ib-IX-V mediates platelet aggregation initiated by von Willebrand factor under high shear stress.
  • It interacts with counter-receptors like alphaMbeta2 on neutrophils and P-selectin.
  • Additional ligands include alpha-thrombin, clotting factors XI/XIIa, and high-molecular-weight kininogen.

Conclusions:

  • Glycoprotein Ib-IX-V is central to thrombus formation and inflammatory processes.
  • Its diverse ligand interactions highlight its importance in vascular biology.
  • The receptor represents a promising therapeutic target for vascular diseases.